Technical Analysis for DOVA - Dova Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 15.1 -5.80% -0.93
DOVA closed down 5.8 percent on Friday, September 20, 2019, on 2.13 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Earnings due: Sep 27

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical DOVA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Crossed Above 50 DMA Bullish -5.80%
Upper Bollinger Band Walk Strength -5.80%
20 DMA Support Bullish -2.58%
Hammer Candlestick Bullish -2.58%
Narrow Range Bar Range Contraction -2.58%
NR7 Range Contraction -2.58%
Upper Bollinger Band Walk Strength -2.58%
Bearish Engulfing Bearish -3.27%

Older signals for DOVA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocytopenia in patients with chronic liver disease (CLD). The Company’s product candidate, avatrombopag is an orally administered thrombopoietin receptor agonist, or TPO-RA. The Company has completed pivotal Phase 3 clinical trials that evaluated avatrombopag for the treatment of thrombocytopenia in patients with CLD. The Company has not generated any revenue.
Medicine Pharmaceutical Blood Orphan Drugs Disorder Platelet Hematopathology Immune Thrombocytopenic Purpura Thrombocytopenia Thrombopoietin Receptor Agonists
Is DOVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 24.4
52 Week Low 5.62
Average Volume 213,396
200-Day Moving Average 10.9973
50-Day Moving Average 15.5826
20-Day Moving Average 15.2925
10-Day Moving Average 15.631
Average True Range 0.8601
ADX 16.32
+DI 26.7901
-DI 24.312
Chandelier Exit (Long, 3 ATRs ) 14.4697
Chandelier Exit (Short, 3 ATRs ) 16.7603
Upper Bollinger Band 16.4586
Lower Bollinger Band 14.1264
Percent B (%b) 0.42
BandWidth 15.250613
MACD Line 0.1373
MACD Signal Line 0.1148
MACD Histogram 0.0225
Fundamentals Value
Market Cap 387.35 Million
Num Shares 25.7 Million
EPS -2.09
Price-to-Earnings (P/E) Ratio -7.22
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 16.81
Resistance 3 (R3) 16.94 16.49 16.53
Resistance 2 (R2) 16.49 16.06 16.43 16.43
Resistance 1 (R1) 15.80 15.79 15.58 15.67 16.34
Pivot Point 15.35 15.35 15.24 15.29 15.35
Support 1 (S1) 14.66 14.92 14.43 14.53 13.86
Support 2 (S2) 14.21 14.65 14.15 13.77
Support 3 (S3) 13.52 14.21 13.67
Support 4 (S4) 13.39